Bayer CEO Doesn’t See Job Cuts as Answer to a Potential Problem

The transcript discusses Bayer's financial performance, job cuts, and strategic adjustments following the Monsanto transaction. It highlights the company's strong results and positive outlook for 2019, despite market volatility. The discussion also covers the impact of German employment laws on job cuts and addresses concerns from activist investors about the company's strategy.

What are the expected growth and EBITDA margin increase for Bayer in 2019?

What advantages does the German model provide in terms of employee discussions?

How many employees is Bayer planning to reduce over the next four years?

What are the key attributes that make Bayer's egg inputs company the best in the world?

What is the context behind Bayer's job reductions?

How does Bayer plan to support its growth and innovation investments going forward?

What strategy does Bayer have in place to deal with activist investors?